Follow
Lingzhi Wang
Lingzhi Wang
Associate Professor, Department of Pharmacology, National University of Singapore
Verified email at nus.edu.sg
Title
Cited by
Cited by
Year
Exosome-mediated metastasis: from epithelial–mesenchymal transition to escape from immunosurveillance
N Syn, L Wang, G Sethi, JP Thiery, BC Goh
Trends in pharmacological sciences 37 (7), 606-617, 2016
4732016
Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges
NL Syn, L Wang, EKH Chow, CT Lim, BC Goh
Trends in biotechnology 35 (7), 665-676, 2017
3572017
Phenolic compounds of Chromolaena odorata protect cultured skin cells from oxidative damage: implication for cutaneous wound healing
TT Phan, L Wang, P See, RJ Grayer, SY Chan, ST Lee
Biological and Pharmaceutical Bulletin 24 (12), 1373-1379, 2001
3382001
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies
BC Goh, SC Lee, LZ Wang, L Fan, JY Guo, J Lamba, E Schuetz, R Lim, ...
Journal of clinical oncology 20 (17), 3683-3690, 2002
3112002
Targeting transcription factor STAT3 for cancer prevention and therapy
EZP Chai, MK Shanmugam, F Arfuso, A Dharmarajan, C Wang, AP Kumar, ...
Pharmacology & therapeutics 162, 86-97, 2016
2722016
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ...
EMBO molecular medicine 5 (7), 1051-1066, 2013
2172013
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of …
W Yeo, HC Chung, SL Chan, LZ Wang, R Lim, J Picus, M Boyer, FKF Mo, ...
Journal of Clinical Oncology 30 (27), 3361, 2012
2002012
A warfarin‐dosing model in Asians that uses single‐nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9
LS Tham, BC Goh, A Nafziger, JY Guo, LZ Wang, R Soong, SC Lee
Clinical Pharmacology & Therapeutics 80 (4), 346-355, 2006
1892006
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer …
B Ma, BC Goh, EH Tan, KC Lam, R Soo, SS Leong, LZ Wang, F Mo, ...
Investigational new drugs 26, 169-173, 2008
1882008
Resveratrol for cancer therapy: Challenges and future perspectives
B Ren, MXY Kwah, C Liu, Z Ma, MK Shanmugam, L Ding, X Xiang, ...
Cancer letters 515, 63-72, 2021
1812021
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
AL Wong, RA Soo, DS Tan, SC Lee, JS Lim, PC Marban, LR Kong, ...
Annals of Oncology 26 (5), 998-1005, 2015
1812015
Insights into biological role of LncRNAs in epithelial-mesenchymal transition
JT Cheng, L Wang, H Wang, FR Tang, WQ Cai, G Sethi, HW Xin, Z Ma
Cells 8 (10), 1178, 2019
1662019
Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects
C Liu, PCL Ho, FC Wong, G Sethi, LZ Wang, BC Goh
Cancer letters 362 (1), 8-14, 2015
1602015
Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL
Q Wen, B Goldenson, SJ Silver, M Schenone, V Dancik, Z Huang, ...
Cell 150 (3), 575-589, 2012
1582012
Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model
J Zhang, KS Ahn, C Kim, MK Shanmugam, KS Siveen, F Arfuso, ...
Antioxidants & redox signaling 24 (11), 575-589, 2016
1532016
Therapeutic potential of gambogic acid, a caged xanthone, to target cancer
K Banik, C Harsha, D Bordoloi, BL Sailo, G Sethi, HC Leong, F Arfuso, ...
Cancer letters 416, 75-86, 2018
1322018
Potential role of genipin in cancer therapy
MK Shanmugam, H Shen, FR Tang, F Arfuso, M Rajesh, L Wang, ...
Pharmacological research 133, 195-200, 2018
1122018
Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
X Dai, KS Ahn, C Kim, KS Siveen, TH Ong, MK Shanmugam, F Li, J Shi, ...
Molecular oncology 9 (4), 818-833, 2015
1052015
Role of novel histone modifications in cancer
MK Shanmugam, F Arfuso, S Arumugam, A Chinnathambi, B Jinsong, ...
Oncotarget 9 (13), 11414, 2018
1032018
Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
Z Ma, X Xiang, S Li, P Xie, Q Gong, BC Goh, L Wang
Seminars in cancer biology 80, 379-390, 2022
1012022
The system can't perform the operation now. Try again later.
Articles 1–20